Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
56.60
+1.10 (1.98%)
Apr 29, 2026, 9:08 AM CET

STO:IBT.B Revenue

Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
747.66M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 20244.00K-73.00K-94.81%
Dec 31, 202377.00K65.00K541.67%
Dec 31, 202212.00K--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
FluoGuide 318.79K
Cantargia AB 316.70M
Medivir AB 8.51M
Oncopeptides AB 71.12M
Xspray Pharma AB 2.47M
Genovis AB (publ.) 129.65M
Intervacc AB 20.09M
Corline Biomedical AB 8.59M
Revenue Rankings